Vimarsana
Biggest News Aggregation in the World

Genelabs Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genelabs Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genelabs Technologies Today - Breaking & Trending Today

Serimmune Announces Appointment of Dr. Gary Schroth to its Scientific Advisory Board - Vimarsana News

Serimmune Announces Appointment of Dr. Gary Schroth to its Scientific Advisory Board

GOLETA, Calif., August 07, 2023--Serimmune, a leader in understanding the antibody repertoire’s role in human disease, announced today the appointment of Gary Schroth, PhD, Vice President and Distinguished Scientist at Illumina, to its Scientific Advisory Board (SAB).

Source: yahoo.com
Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer - Vimarsana News

Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer

Dr. Liu is a clinical leader who brings expertise in the discovery, development, and regulatory approval of oncology therapies worldwide Ms. Wentworth has over two decades of industry experience in... | July 18, 2022

Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief - Vimarsana News

Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief

Dr. Liu is a clinical leader who brings expertise in the discovery, development, and regulatory approval of oncology therapies worldwideMs. Wentworth has over two decades of industry experience in domestic and international regulatory and quality affairsNEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a bi...

Nuvation Bio Appoints David Li - GuruFocus.com - Vimarsana News

Nuvation Bio Appoints David Li - GuruFocus.com

GuruFocus Article or News written by Business Wire and the topic is about:

Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer - Vimarsana News

Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer

Mr. Driscoll has over 25 years of biotech executive experience and most recently served as the CFO of Flexion Therapeutics through its sale to Pacira BioSciences for up to $1 billion ... | March 28, 2022